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Synthesis of bioactive quinazolin-4(3H)-one derivatives via 
microwave activation tailored by phase-transfer catalysis
A series of nine new 2,3-disubstituted 4(3H)-quinazolin-4-one deri-
vatives was furnished starting from the 2-propyl-4(3H)-quinazo-
line-4-one (2). The reinvestigation of the key starting quinazolinone 
2 was performed under microwave irradiation (MW) and solvent- 
-free conditions. Combination of MW and phase-transfer catalysis 
using tetrabutylammonium benzoate (TBAB) as a novel neutral 
ionic catalyst was used for carrying out N-alkylation and condensa-
tion reactions of compound 2 as a simple, efficient and eco-friendly 
technique. The structure of the synthesized compounds was eluci-
dated using different spectral and chemical analyses. In vitro anti-
microbial activity of the compounds was investigated against four 
bacterial and two fungal strains; very modest activity was achieved. 
Some of the synthesized compounds were screened for their antitu-
mor activity against different human tumor cell lines. The screened 
compounds exhibited a significant antitumor activity on some of the 
cancer cell lines, melanoma (SK-MEL-2), ovarian cancer (IGROV1), 
renal cancer (TK-10), prostate cancer (PC-3), breast cancer (MCF7) 
and colon cancer (HT29). The most active, even more active than the 
reference 5-fluorouracil, were found to be ethyl 4-[(4-oxo-2-propyl-
quinazolin-3(4H)-yl)methyl]benzoate (3c), 3-{2-[6-(pyrrolidin-1-yl-sul-
fonyl)-1,2,3,4-tetrahydroquinoline]-2-oxoethyl}-2-propylquinazolin- 
-4(3H)-one (3e), N’-[(E)-(2H-1,3-benzodioxo-5-yl)methyl idene]-2-(4- 
-oxo-2-propylquinazolin-3(4H)-yl)acetohydrazide (10a), N’-[(E)-(4- 
-hydroxyphenyl)methylidene]-2-(4-oxo-2-propylquinazo-lin-3(4H)-
-yl)acetohydrazide (10b) and N’-[(E)-(4-nitrophenyl)methyl idene]-2-
-(4-oxo-2-propylquinazolin-3(4H)-yl)acetohydrazide (10c).
Keywords: solid-liquid transfer catalysis, microwave-assisted reac-
tion, 2-propylquinazolinone, N-alkylation, 2,3-disubstituted 
quinazolinones, anticancer activity
Quinazolin-4(3H)-ones are well-known versatile nitrogen heterocyclic compounds. 
Their occurrence and properties have been of interest to chemists on the account of their 
pharmacological and medicinal activities (1–5). The attractive natural and synthetic quin-
azolin-4(3H)-ones include methaqualone (6), piriqualone (7), chrysogine (8) and l-vasici-
none (9).
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A multitude of interesting approaches toward the modern methodologies for the ra-
tional synthesis of 2,3-disubstituted quinazolin-4(3H)-ones has been reported during the 
past years. In particular, Smith and others (10) studied the modifications of the quinazolin- 
-4(3H)-ones ring synthesis via lithiation. Searching for new synthetic methodologies of 
2,3-disubstituted quinazolin-4(3H)-ones in order to improve their synthetic medicinal 
 applications are in demand.
Accordingly, uses of ultrasonic, microwaves, solvent-free conditions, as well as ionic 
catalysts and phase-transfer catalysis are modern attractive synthetic approaches which 
were successfully applied for heterocycles synthesis, quinazolin-4(3H)-ones in particular 
(11). No one can deny that MW technique is announced as a green approach characterized 
as clean, simple, efficient and environment-friendly technique.
Majority of the reported 4(3H)-quinazolin-4-one derivatives are synthesized follow-
ing conventional methods of heating (12); reactants are slowly activated by a conventional 
external heat source. There are very few reports (13) regarding the microwave-assisted 
synthesis of 4(3H)-quinazolinone derivatives. During recent years, MW has been used for 
carrying out chemical reactions as a useful non-conventional energy source for the 4(3H)- 
-quinazolinones synthesis (14).
Due to such observations, much interest has been devoted to the synthesis of novel 
2,3-disubstituted quinazolinones 3a-e and 4a-d bearing moieties and functional groups 
affecting their biological activities. Moreover, interesting quinazolinone derivatives 5–10 
were re-investigated and their biological activities were evaluated.
EXPERIMENTAL
Reagents and instrument 
All of the used reagents and solvents were purchased from Merck (Germany).  Solvents 
were dried according to the literature when necessary. The purity of the new compounds 
was checked with TLC. Büchi (Switzerland) melting point apparatus was used; melting 
points were uncorrected. MW reactions were performed using a mini-lab microwave 
 catalytic reactor WBFY-205, ZZKD, Henan, China. IR spectra were recorded on FT-IR 
 Nicolet Impact 400D (Spectral lab Scientific Inc. Canada), in KBr pellets (n in cm–1). 1H- and 
13C NMR spectra were obtained on Bruker at 400 and 100 MHz (Bruker AV400 spectro-
meter, Bruker, USA), resp., in CDCl3 or DMSO-d6 (d in ppm relative to Me4Si as the internal 
standard, J in Hz). DEPT135-NMR spectroscopy (Bruker AV400 spectrometer, Bruker, 
USA) was used where appropriate, to aid the assignment of signals in the 1H- and 13C NMR 
spectra. For HRMS (FAB+) JEOL JMS-SX 102A instrument (Jeol, Japan) was used.
Syntheses
2-Propyl-4H-3,1-benzoxazinone (1) was prepared according to literature (15).
2-Propylquinazolin-4(3H)-one (2). – A mixture of 2-propyl-4H-3,1-benzoxazinone 1 (10 
mmol, 1.89 g) and ammonium acetate (40 mmol, 3.08 g) was irradiated in MW bath reactor 
at 100 W and 120 °C for 2–5 min. The resulting crude was filtered off, washed with cold 
water and recrystallized from petrol ether to give compound 2.
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General procedure for the formation of compounds 3a-e. Method A (16). – To a solution of 
quinazolinone 2 (10 mmol, 1.88 g) in DMF (20 mL) K2CO3 was added (12 mmol, 1.66 g). The 
reaction mixture was stirred at 60 °C for 30 min, then KI (5 mmol, 0.88 g) was added and 
the formed mixture was stirred for another 15 min. Solution of respective alkylating agents 
(ethyl chloroacetate, chloroacetyl chloride, ethyl 4-(bromomethyl)benzoate, 2-chloro-N-
phenylpropanamide, 2-chloro-1-[6-(pyrrolidine-1-sulfonyl)-3,4-dihydroquinolin-1(2H)-yl]
ethan-1-one; 0.5 mL) in DMF (10 mL), was dropped slowly into the mixture. After 4 h at 60 
°C, the mixture was allowed to cool down and then was poured into ice-cold water. The 
solid that formed was scrubbed with water, filtered and crystallized using the suitable 
solvent to give the respective compounds 3a-e.
Method B. – A mixture of quinazolinone 2 (40 mmol, 7.52 g), K2CO3 (80 mmol, 11.04 g) 
and tetrabutylammonium benzoate (TBAB, 4 mmol, 14.54 g) was irradiated in an MW bath 
reactor at 800 W and 120 °C for 2–4 min. Alkylating agent (namely, ethyl chloroacetate, 
chloroacetyl chloride, ethyl 4-(bromomethyl)benzoate, 2-chloro-N-phenylpropanamide, 
2-chloro-1-[6-(pyrrolidine-1-sulfonyl)-3,4-dihydroquinolin-1(2H)-yl]ethan-1-one) (50 
mmol) was added, the mixture was again subjected to MW irradiation for the appropriate 
time (5–12 min). After finalization of the reaction (followed by TLC), the reaction mixture 
was cooled down to r.t. and water was added. The formed precipitate was scrubbed and 
crystallized from a suitable solvent to give 3a-e, resp.
The following compounds were prepared: ethyl (4-oxo-2-propylquinazolin-3(4H)-yl)
acetate (3a), (4-oxo-2-propylquinazolin-3(4H)-yl)acetyl chloride (3b), ethyl 4-[(4-oxo-2-
propyl quinazolin-3(4H)-yl)methyl]benzoate (3c), 2-(4-oxo-2-propylquinazolin-3(4H)-yl)-N- 
-phenylpropanamide (3d) and 3-{2-[6-(pyrrolidin-1-yl-sulfonyl)-1,2,3,4-tetrahydroquinoline]- 
-2-oxoethyl}-2-propylquinazolin-4(3H)-one (3e).
General procedure for the synthesis of quinazolinones 4a-d. – A suspension of 2-propylquina-
zolinone (2, 5 mmol, 0.94 g), aromatic aldehyde (vetraldehyde, 4-N,N-dimethylaminobenz-
aldehyde, piperonal, 4-chlorobenzaldehyde) (5 mmol), TBAB (2.5 mmol, 9.09 g) and K2CO3 
(2.5 mmol, 3.46 g) in 15 mL of distilled water, was mixed well with the aid of a glass rod 
and irradiated in MW bath reactor at 600 W and 120 °C for 8–10 min. After cooling, the 
reaction mixture was acidified with dilute HCl. The crude product was separated by filtra-
tion followed by scrubbing with water and crystallization from EtOH and the following 
respective quinazolinone derivatives were prepared: 2-[(1E)-1-(3,4-dimethoxyphenyl)but- 
-1-en-2-yl]quinazolin-4(3H)-one (4a), 2-{(1E)-1-[4-(dimethylamino)phenyl]but-1-en-2-yl}
quinazolin-4(3H)-one (4b), 2-[(1E)-1-(2H-1,3-benzodioxo-5-yl)but-1-en-2-yl]quinazolin-
4(3H)-one (4c) and 2-[(1E)-1-(4-chlorophenyl)but-1-en-2-yl]quinazolin-4(3H)-one (4d).
Table I displays reaction conditions and yields under microwave heating and conven-
tional heating procedures of 2-propyl-quinazolinone (2) with different alkylating agents.
Compounds 5–10a-c were prepared according to the previous literature with slight 
modifications (17).
2-(4-Oxo-2-propylquinazolin-3(4H)-yl)acetohydrazide (5). – A suspension of the ester 3a 
(10 mmol, 2.74 g) and hydrazine hydrate (15 mmol, 0.75 g) in absolute ethanol (20 mL) was 
refluxed for 3 h. The reaction mixture was concentrated and then cooled down to r.t. The 
formed solid was filtered and recrystallized from EtOH to give acetohydrazide 5.
3-[(5-Methyl-1,3,4-oxadiazol-2-yl)methyl]-2-propylquinazolin-4(3H)-one (6). – A suspen-
sion of acetohydrazide 5 (10 mmol, 2.60 g) in 15 mL of acetic acid anhydride was refluxed 
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for 3 h. The solid that formed after cooling was filtered off and scrubbed with benzene to 
give quinazolinone derivative 6.
General procedure for quinazolinones 7–9. – A mixture of acetohydrazide 5 (10 mmol, 2.60 g) 
and acetylacetone, ethyl acetoacetate or 3-nitrophthalic anhydride (10 mmol) in absolute 
EtOH (30 mL) was heated at 70 °C under reflux for 3 h. The crude solid that precipitated 
after cooling was filtered off and scrubbed with EtOH and the following quinazolinone 
derivatives were prepared: 3-[2-(3,5-dimethyl-1H-pyrazol-1-yl)-2-oxoethyl]-2-propylquina-
zolin-4(3H)-one (7), 3-{[5-(2-oxopropyl)-1,3,4-oxadiazol-2-yl]methyl}-2-propylquinazolin- 
-4(3H)-one (8) and N-(4-nitro-1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)-2-(4-oxo-2-propyl-
quinazolin-3(4H)-yl)acetamide (9).
General procedure for acetohydrazides 10a-c. – An equimolar mixture of acetohydrazide 
5 (10 mmol, 2.60 g) and aromatic aldehyde, namely, piperonal, 4-hydroxybenzaldehyde and 
4-nitrobenzaldehyde (10 mmol) in 30 mL absolute EtOH was refluxed for 3 h. The reaction 
mixture was left overnight and the separated solid was filtered off and recrystallized from 





Physicochemical properties and spectral data of the synthesized compounds are pre-
sented in Tables II and III.

















5–6 120 96 71
3d NH
Cl O






10–12 140 88 59
a The reaction proceeds in the presence of K2CO3 and TBAB at 800 W.
b Conventional thermal heating, K2CO3, KI, 60 °C.
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Biological activity
Antimicrobial activity. – Antimicrobial activity of all compounds was determined by 
agar well diffusion method (18). Microbial inocula were uniformly spread using a sterile 
L-shaped rod on sterile Petri dishes loaded with nutrient agar and potato dextrose agar for 
antibacterial and antifungal tests, resp. Screened compounds were dissolved in DMSO in 
order to prepare solutions in the concentration range 10–30 mmol L–1. Reference substances 
were amphotericin B for fungi, ampicillin and gentamicin for Gram-positive and Gram- 
-negative bacteria, resp.; all were dissolved in DMSO in concentration around 3 mmol L–1.
A hundred mL of screened compounds and/or reference substance solutions were 
added to 5 wells (6-mm diameter holes scooped out with a sterile cork borer). They were 
then incubated under aerobic conditions (24 h at 37 °C for bacteria and 48 h at 28 °C for 
fungi). Inhibition zones were determined; the diameter was expressed in millimeters. Fur-
thermore, minimum inhibitory concentration (MIC) for substances with potent antimicro-
bial activity was determined. Thus, the compounds were dissolved in DMSO in order to 
prepare a series of different concentrations (150, 275, 325, 425 and 600 mmol L–1). Results 
are presented in Table IV.
Antitumor activity. – In vitro screening of compounds 3c-e and 10a-c for its antitumor 
activity were performed where a single dose (25 μmol L–1) of the test compounds was used 
against 60 cell lines panel assay (19, 20).
After a drug-free incubation period of 24 h, the test compound was added and incu-
bated for another 48 h, followed by assaying the cell growth using the sulforhodamine B 
(SRB) protocol (21). The results were presented as percentage growth inhibition (GI50) 
caused by the tested compounds. The parameters GI50 and LC50 (median lethal concentra-
tion) were calculated for each cell line (Table V).
RESULTS AND DISCUSSION
Chemistry
Synthesis of 2-propyl-4(3H)-quinazolin-4-one (2) in 96 % yield has been performed 
using the ammonolysis of 3,1-benzoxazin-4-one (1) with ammonium acetate under the ac-
tion of MW irradiation and solvent-free conditions (see Scheme 1).
In the conventional method, the reaction was carried out via the fusion at an elevated 
temperature for 3 h, and consequently leading to the degradation process and low yield of 
the isolated product. The main advantages of applying microwave-assisted technology are 
that the completion of the reaction in few minutes (3–5 min) and the satisfactory yields (96 %) 
of the product, higher than those achieved by traditional methods (see Scheme 1 and Table I). 
The structure of the prepared quinazolinone 2 was elucidated using elemental and spectral 
analysis (Tables II and III).
In the present study, the authors decided to use a catalytic procedure through combin-
ing MW and the phase-transfer catalytic (PTC) conditions, as this technique has found 
great applications in essentially all disciplines of organic synthesis (22). The solid-liquid 
PTC has been described as an attractive procedure in the heterocyclic synthesis and was 
171
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under numerous investigations (23). Formation of N-alkylated quinazolinones 3a-e is pre-
sented in Scheme 1. This method is associated with anionic activation, where a catalytic 

























O, 600 MW, 8-10 min
a R = CH2COOCH2CH3
b R = CH2COCl
c R = CH2C6H4COOCH2CH3
d R = CH(CH3)CONHC6H5
e R = 6-pyrrolidin-1-yl-sulfonyl)-
-1,2,3,4-tetrahydroquinoline
a R = C6H3(OCH3)2 (3,4)
b R = C6H4N(CH3)2 (4)
c R = C6H3(O2CH2) (3,4)
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joined the pure reactants blend (24). For the reactions percolate in the liquid organic phase, 
the electrophilic alkyl halide was chosen as the model constitute which, therefore, acts as 
the reactant, as well as the liquid organic phase for the reaction. The combination of solid-
liquid PTC and MW irradiation was proven to give the best results (25).
Under these circumstances, a simple, efficient and eco-friendly procedure has been 
developed using TBAB as a novel neutral ionic liquid catalyst for the construction of new 
3-substituted-2-propyl-4(3H)-quinazolin-4-one derivatives 3a-e. The rapid N-alkylation 
of 2-propyl-4(3H)-quinazolin-4-one (2) using different alkylating agents (namely, ethyl 
chloroacetate, chloroacetyl chloride, ethyl 4-(bromomethyl)benzoate, 2-chloro-N-phenyl-
propanamide, 2-chloro-1-[6-(pyrrolidine-1-sulfonyl)-3,4-dihydroquinolin-1(2H)-yl]ethan- 
-1-one, resp.) was performed under the action of MW irradiation and PTC solvent-free 
conditions (25). The quinazolinones 3a-e were obtained in high yields with short reaction 
times. Yields exceeded 80 %, a dramatic improvement when compared with those from 
conventional heating. The best yield, for example, was from chloroacetyl chloride in the 
presence of TBAB as the catalyst at 120 °C (see Scheme 1 and Table I).
Classically, 2-propylquinazolin-4(3H)-one (2) has been promoted to react with diver-
gent aromatic aldehydes in glacial acetic acid, generating 2-(1-arylbut-1-en-2-yl)quinazolin-
4(3H)-ones (14, 26). Gupta and Wakhloo (27) studied the well-known Knoevenagel conden-
sation under MW to produce unsaturated acids. They carried out condensation between 
carbonyl compounds and active methylene compounds using tetrabutylammonium bro-
mide and potassium carbonate in water under MW irradiation.
In the present work, 2-propylquinazolinone 2 was endowed to react with distinctive 
aromatic aldehydes (namely, vetraldehyde, 4-N,N-dimethylaminobenzaldehyde, pipero-
nal, 4-chlorobenzaldehyde) under the above-mentioned conditions of Gupta and Wakhloo 
(27). The mixture of 2-propylquinazolinone 2 and aldehydes was adsorbed on potassium 
carbonate, then irradiated in MW bath reactor at 600 W for 8–10 min. 2-(1-Arylbut-1-en-2-yl)
quinazolinone derivatives 4a-d were achieved in excellent yields and purity (see Scheme 
1, Tables I and II). In such a reaction, water as a solvent was used; this is often intended to 
exploit the hydrophobic effect (28). Such effect can be explained in terms of the fact that 
water, at elevated temperature, has a markedly lower dielectric constant (20 at 300 °C); this 
value seems comparable with the solvents like acetone, at ambient temperature (29). So, 
one can consider water at an elevated temperature to behave as a pseudo-organic solvent, 
a good environmentally replacement for the organic solvent.
Furthermore, the chemical structure of ester 3a was confirmed chemically via its hydra-
zinolysis using hydrazine hydrate in boiling ethanol to afford 2-(4-oxo-2-propylquinazo-
lin-4(3H)-yl)acetohydrazide 5. Subsequently, the acetohydrazide 5 was functionalized as 
the key starting material for obtaining some heterocycles with potential biological activity. 
In this respect, acetohydrazide 5 has been reacted with the acetic acid anhydride, acetyl-
acetone, ethyl acetoacetate, 3-nitrophthalic acid anhydride and the compounds 6–9 were 
afforded, resp. Additionally, its condensation with aromatic aldehydes, namely, piperonal, 
4-hydroxy benzaldehyde, and 4-nitrobenzaldehyde in boiling ethanol at 70 °C furnishing 
the analogous aminoquinazolinones 10a-c (see Scheme 2, Tables II and III).
Biological activity
Antimicrobial activity. – The compounds were tested against two Gram-positive bacte-
ria (Bacillus subtilis, ATCC-19635 and Streptococcus aureus, ATCC-25923), two Gram-negative 
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bacteria (Escherichia coli, ATCC-63059 and Pseudomonas aeruginosa, ATCC-27853) and two 
pathogenic fungi (Aspergillus niger, ATCC-700608 and Candida albicans, ATCC-90028). Table 
IV revealed that only compounds 3e and 4d displayed promising activity against S. aureus 
and E. coli (MIC = 150 mmol L–1) as compared to the standard control drugs (ampicillin, 70 
mmol L–1 and gentamicin, 60 mmol L–1). Remaining compounds exhibited lower activity.
Only compound 7 (MIC = 150 mmol L–1) exhibited promising activity against the fun-
gal strains studied compared to the standard drug used (amphotericin B, 35 mmol L–1) 
(Table IV).
Antitumor activity. – Compounds 3c,e and 10a-c were evaluated at five different con-
centrations (0.001, 0.1, 1.0, 10, and 100 mmol L–1) against 60 different human cell line panel 
assay using the known drug 5-fluorouracil (5-FU) as a positive control (30).
It was envisioned that all screened compounds displayed activities against the tested 
cell lines with positive cytotoxic effects (PCE). Considering broad-spectrum antitumor 
activity, insightful examination of the data presented in Table IV showed that compounds 
3e and 10a are the most active quinazolinone derivatives displaying selectivity towards 
numerous cell lines.
Compound 3e (LC50 > 100 mmol L–1) exhibited remarkable growth inhibitory activity 
pattern against SK-MEL-2 & M14 (melanoma cancer) (GI50 3.34 and 5.18 mmol L–1, resp.), 
IGROVI (ovarian cancer) (GI50 2.50 mmol L–1), TK-10 (renal cancer) (GI50 2.85 mmol L–1), PC-3 
(prostate cancer) (GI50 4.26 mmol L–1), MCF7 (breast cancer) (GI50 3.05 mmol L–1) and HT29 
(colon) (GI50 8.12 mmol L–1) in comparison to the standard drug 5-FU (60.7, 43.2, 36.8, 45.3, 
23.4, 67.6 and 33.9 mmol L–1, resp.) (Table V). Also, compound 10a (LC50 > 100 mmol L–1) 
exhibited growth inhibitory activity pattern against PC-3 (prostate cancer) (GI50 3.48 mmol 
L–1), MCF7 (breast cancer) (GI50 2.19 mmol L–1) and HCC-2998 (colon cancer) (GI50 2.84 mmol 
L–1) in comparison to the standard drug 5-FU (23.4, 67.6 and 22.5 mmol L–1, resp.) (Table V). 
The rest of the tested compounds (3c, 3d, 10b and 10c) showed also high activity against 
HCC-2998, PC-3 and MCF7, and moderate to low activity against the rest of studied human 
cell lines. Such results are encouraging the authors with the hope of finding new potential 
antitumor agents. In addition, Table V also revealed that, according to LC50, these compounds 
were of low toxicity for the normal human cell lines, which is an inevitable requirement 
for potential antitumor agents.
Structure-activity relationship
For antitumor activity, it was envisioned that the more hybridity of quinazolinone 
with a high functionalized 2nd chromophore at the 3-position ([6-(pyrrolidin-1-yl-sulfonyl)- 
-1,2,3,4-tetrahydroquinoline] and (1,3-benzodioxo-5-yl)methylidene, for 3e and 10a, resp., 
as the antitumor activity is excellent. The presence of 6-(pyrrolidin-1-yl-sulfonyl)-1,2,3,4- 
-tetrahydroquinoline moiety in compound 3e increased the activity against M14, SK-MEL-2, 
IGROVI, TK-10, PC-3, MCF7 and HT29 cell lines. However, the existence of ethyl 4-(methyl)-
benzoate and phenylpropanamide in quinazolinones 3c and 3d, resp., decreased the activity 
towards M14, SK-MEL-2, PC-3 and MCF7 cell lines.
Moreover, the existence of piperonal moiety has an excellent influence on activity 
against PC-3, MCF7, HCC-2298, TK10 and SK-MEL-2 cell lines. This antitumor activity 
against the mentioned cell lines of compound 10a emphasizes that the presence of 1,3-ben-
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zodioxole moiety at position-3 is superior in its effect to the electronic effect of either the 
electron-donating OH-group or the electron-withdrawing NO2-group existing in quinazo-
linones 10b and 10c, resp.
In the present study, the highest antibacterial activity was exerted by quinazolinones 
bearing sulfonamide or electron-withdrawing chloro group (3e and 4d), whereas the best 
antifungal efficiency has been observed with compound 7 bearing dimethyl-pyrazolyl at 
position-3.
CONCLUSIONS
The authors successfully endeavor to reinvestigate the synthesis of 2-propylquinazo-
lin-4(3H)-one (2) in excellent yield using microwave-assisted reaction under solvent-free 
conditions. Comparison between conventional heating and microwave irradiation reve-
aled the powerful and selective microwaves action on producing the N-alkylated quin-
azolinones namely, ethyl (4-oxo-2-propylquinazolin-3(4H)-yl)acetate (3a), (4-oxo-2-propyl-
quinazolin-3(4H)-yl)acetyl chloride (3b), ethyl 4-[(4-oxo-2-propylquinazolin-3(4H)-yl)
methyl]benzoate (3c), 2-(4-oxo-2-propylquinazolin-3(4H)-yl)-N-phenylpropanamide (3d) 
and 3-{2-[6-(pyrrolidin-1-yl-sulfonyl)-1,2,3,4-tetrahydroquinoline]-2-oxoethyl}-2-pro-
pylquinazolin-4(3H)-one (3e). In addition, the combination of phase-transfer catalysis and 
microwaves resulted in producing the more interesting functionalized heterocycles 4a-d 
containing the important 4(3H)-quinazolinone core. We hereby highlighted the potential 
of some of the synthesized heterocycles as potential antitumor agents. Quinazolinone core 
that endows propyl group at 2-position and substitution at 3rd position (generation the 2nd 
chromophore at 3-position) was found superior in bioactivity.
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